Tumor-infiltrating lymphocytes and macrophages as a significant prognostic factor in biliary tract cancer

Background The impact of tumor-infiltrating lymphocytes (TILs) and tumor-associated macrophages (TAMs) on the prognosis of biliary tract cancer (BTC) is not completely understood. Therefore, in our study, we investigated the effects of the various immune cells infiltration in tumor microenvironment (TME). Methods A total of 130 patients with BTC who underwent surgical treatment at our institution were enrolled in this study. We retrospectively evaluated TILs and TAMs with immunohistochemical staining. Results With CD8-high, CD4-high, FOXP3-high, and CD68-low in TME as one factor, we calculated Immunoscore according to the number of factors. The high Immunoscore group showed significantly superior overall survival (OS) and recurrence-free survival (RFS) than the low Immunoscore group (median OS, 60.8 vs. 26.4 months, p = 0.001; median RFS not reached vs. 17.2 months, p < 0.001). Also, high Immunoscore was an independent good prognostic factor for OS and RFS (hazards ratio 2.05 and 2.41 and p = 0.01 and p = 0.001, respectively). Conclusions High Immunoscore group had significantly superior OS and RFS and was an independent good prognostic factor for OS and RFS.

[1]  J. Cui,et al.  NK Cell Therapy: A Rising Star in Cancer Treatment , 2021, Cancers.

[2]  S. Salek-Ardakani,et al.  CD8+ T Cell Exhaustion in Cancer , 2021, Frontiers in Immunology.

[3]  Zemin Zhang,et al.  The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications , 2020, Cellular & Molecular Immunology.

[4]  S. Kubo,et al.  Preoperative Neutrophil-to-lymphocyte Ratio Predicts Tumor-infiltrating CD8+ T Cells in Biliary Tract Cancer , 2020, AntiCancer Research.

[5]  M. Rugge,et al.  Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes. , 2020, The oncologist.

[6]  N. Tumino,et al.  Exploiting Human NK Cells in Tumor Therapy , 2020, Frontiers in Immunology.

[7]  C. Conboy,et al.  Immunobiology of cholangiocarcinoma , 2019, JHEP reports.

[8]  Brian Ruffell,et al.  Macrophages as regulators of tumour immunity and immunotherapy , 2019, Nature Reviews Immunology.

[9]  S. Kwon,et al.  Tumor-Associated Macrophages as Potential Prognostic Biomarkers of Invasive Breast Cancer , 2019, Journal of breast cancer.

[10]  Haiyan Si,et al.  Efficacy and safety of nivolumab for metastatic biliary tract cancer , 2019, OncoTargets and therapy.

[11]  Shasha Liu,et al.  Fates of CD8+ T cells in Tumor Microenvironment , 2018, Computational and structural biotechnology journal.

[12]  K. Hirakawa,et al.  Tumor-infiltrating Immune Cells in H&E-stained Sections of Colorectal Cancer Tissue as a Reasonable Immunological Biomarker , 2018, AntiCancer Research.

[13]  J. Haanen,et al.  Adoptive cellular therapies: the current landscape , 2018, Virchows Archiv.

[14]  S. Tomita,et al.  Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy , 2018, ESMO Open.

[15]  J. Borst,et al.  CD4+ T cell help in cancer immunology and immunotherapy , 2018, Nature Reviews Immunology.

[16]  M. Dhiman,et al.  Role of immune system in tumor progression and carcinogenesis , 2018, Journal of cellular biochemistry.

[17]  K. Hirakawa,et al.  A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections , 2018, PloS one.

[18]  K. Hirakawa,et al.  Significance of tumor‐infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer , 2018, Cancer science.

[19]  T. Ishiko,et al.  Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma , 2017, British Journal of Cancer.

[20]  Zhiqiang Wu,et al.  Phase I Study of Chimeric Antigen Receptor–Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers , 2017, Clinical Cancer Research.

[21]  G. Tonini,et al.  Classification of M1/M2-polarized human macrophages by label-free hyperspectral reflectance confocal microscopy and multivariate analysis , 2017, Scientific Reports.

[22]  K. Hirakawa,et al.  The peripheral monocyte count is associated with the density of tumor-associated macrophages in the tumor microenvironment of colorectal cancer: a retrospective study , 2017, BMC Cancer.

[23]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[24]  H. Kijima,et al.  Prognostic Impact of CD163+ Macrophages in Tumor Stroma and CD8+ T-Cells in Cancer Cell Nests in Invasive Extrahepatic Bile Duct Cancer. , 2017, Anticancer research.

[25]  M. Disis,et al.  Clinical significance of tumor-infiltrating lymphocytes in breast cancer , 2016, Journal of Immunotherapy for Cancer.

[26]  Y. Mao,et al.  The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis , 2016, PloS one.

[27]  M. Schmelzle,et al.  Prognostic significance of macrophage invasion in hilar cholangiocarcinoma , 2015, BMC Cancer.

[28]  T. Takada,et al.  Classification of biliary tract cancers established by the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery: 3rd English edition , 2015, Journal of hepato-biliary-pancreatic sciences.

[29]  Jeffrey W Pollard,et al.  Tumor-associated macrophages: from mechanisms to therapy. , 2014, Immunity.

[30]  H. Cantor,et al.  CD4 T-cell Subsets and Tumor Immunity: The Helpful and the Not-so-Helpful , 2014, Cancer Immunology Research.

[31]  A. Warth,et al.  Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer , 2013, British Journal of Cancer.

[32]  Yuquan Wei,et al.  Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature , 2012, PloS one.

[33]  Karin Jirström,et al.  The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients , 2012, BMC Cancer.

[34]  S. Rosenberg,et al.  Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes , 2012, Journal of immunotherapy.

[35]  R. deLeeuw,et al.  The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature , 2012, Clinical Cancer Research.

[36]  C. Sautès-Fridman,et al.  The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.

[37]  Douglas Hanahan,et al.  Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .

[38]  Yi Xia,et al.  High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma , 2012, Medical Oncology.

[39]  F. Ghiringhelli,et al.  Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer , 2011, Cancer Immunology, Immunotherapy.

[40]  J. Schlom,et al.  Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity , 2011, Experimental biology and medicine.

[41]  H. Baba,et al.  Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma , 2010, Cancer science.

[42]  N. Zeps,et al.  Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  P. Allavena,et al.  The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. , 2008, Critical reviews in oncology/hematology.

[44]  S. Hirohashi,et al.  FOXP3+ Regulatory T Cells Affect the Development and Progression of Hepatocarcinogenesis , 2007, Clinical Cancer Research.

[45]  S. Hirohashi,et al.  Prevalence of FOXP3+ Regulatory T Cells Increases During the Progression of Pancreatic Ductal Adenocarcinoma and Its Premalignant Lesions , 2006, Clinical Cancer Research.

[46]  T. Oshikiri,et al.  Clinical significance of immune cell infiltration within gallbladder cancer , 2003, British Journal of Cancer.